Longevity Health Holdings is registering 44,382 common shares tied to a $416,667 10% senior secured convertible note due February 29, 2028. The financing creates a direct obligation, is backed by Collateral and Subsidiary guarantees, and can result in additional common stock through conversion.

Key Highlights

  • The note carries a 10% rate and matures on February 29, 2028.
  • Warrants issued on January 2, 2025 will have their exercise price reduced to $1.38, while issuable shares rise to 712,307.
  • Elevai Skincare, Carmell Regen Med and Carmell Cosmetics are providing subsidiary guarantees to Puritan Partners.

Longevity Health Holdings, Inc. (OTC: XAGE) is registering 44,382 common shares connected with a $416,667 senior secured convertible note issued to Puritan Partners LLC. The note carries a 10% rate and is due February 29, 2028, creating a direct financial obligation for the company.

$416,667 Note Backed

by Collateral The transaction documents are dated August 31, 2026, and identify Puritan Partners LLC as the purchaser and collateral agent. Security arrangements include an amended and restated security agreement and a separate intellectual property security agreement covering the company and its subsidiaries. Elevai Skincare, Inc. Carmell Regen Med Corporation and Carmell Cosmetics Corporation have guaranteed the obligations in favor of Puritan Partners. Longevity Health Holdings said proceeds from the notes are intended for working capital, subject to the settlement agreement dated August 13, 2026, involving Puritan Partners, the company and Carmell Regen Med Corporation. Shares issuable on exercise will increase from 292,929 to 712,307. Either party may terminate the purchase agreement if closing has not occurred by September 15, 2026.